Skip to main content
Clinical Trials/NCT05645133
NCT05645133
Terminated
Not Applicable

Evaluation of a Pediatric Reference Interval Using QPLUS System

HemoSonics LLC1 site in 1 country93 target enrollmentFebruary 27, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pediatric ALL
Sponsor
HemoSonics LLC
Enrollment
93
Locations
1
Primary Endpoint
Reference range interval for measurement of clot time (CT) parameter
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

Evaluation of coagulation results reported by the Qplus Quantra System to determine pediatric reference range intervals.

Detailed Description

Single center observational study of the pediatric patient population (\< 18yrs) with normal coagulation function to determine the reference range interval for the clotting parameters reported by the Quantra QPlus system.

Registry
clinicaltrials.gov
Start Date
February 27, 2023
End Date
June 10, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Scheduled for procedure requiring anesthesia
  • Access to blood sampling
  • Consented

Exclusion Criteria

  • \>18yrs of age
  • pre-term babies
  • patients with know hematological disorders
  • Difficult to obtain blood sampling
  • Has received a blood product transfusion within the last 24hrs.
  • Legal guardian unwilling to consent

Outcomes

Primary Outcomes

Reference range interval for measurement of clot time (CT) parameter

Time Frame: Baseline, after access placement before any procedures

Reference range interval determined in this study will serve as the reference for CT results in this particular population

Reference range interval for measurement of clot stiffness (CS) parameter

Time Frame: Baseline, after access placement before any procedures

Reference range interval determined in this study will serve as the reference for CS results in this particular population

Reference range interval for measurement of Platelet Contribution to clot stiffness (PCS) parameter

Time Frame: Baseline, after access placement before any procedures

Reference range interval determined in this study will serve as the reference for PCS results in this particular population

Reference range interval for measurement of clot time (CTH) parameter

Time Frame: Baseline, after access placement before any procedures

Reference range interval determined in this study will serve as the reference for CTH results in this particular population

Reference range interval for measurement of Fibrinogen Contribution to clot stiffness (FCS) parameter

Time Frame: Baseline, after access placement before any procedures

Reference range interval determined in this study will serve as the reference for FCS results in this particular population

Study Sites (1)

Loading locations...

Similar Trials